Oncotarget

Research Papers:

Depletion of FAP+ cells reduces immunosuppressive cells and improves metabolism and functions CD8+T cells within tumors

Ying Zhang and Hildegund C.J. Ertl _

PDF  |  HTML  |  How to cite  |  Order a Reprint

Oncotarget. 2016; 7:23282-23299. https://doi.org/10.18632/oncotarget.7818

Metrics: PDF 1246 views  |   HTML 1372 views  |   ?  


Abstract

Ying Zhang1,2, Hildegund C.J. Ertl2

1Gene Therapy and Vaccines Program, University of Pennsylvania, Philadelphia, Pennsylvania, USA

2The Wistar Institute, Philadelphia, Pennsylvania, USA

Correspondence to:

Hildegund C.J. Ertl, e-mail: ertl@wistar.upenn.edu

Keywords: FAP+ fibroblasts, cancer vaccine, metabolic stress, T cell exhaustion, immunosuppressive cells

Received: December 22, 2015    Accepted: February 14, 2016    Published: March 01, 2016

ABSTRACT

The tumor stroma, which is essential to support growth and metastasis of malignant cells, provides targets for active immunotherapy of cancer. Previous studies have shown that depleting fibroblast activation protein (FAP)-expressing stromal cells reduces tumor progression and concomitantly increases tumor antigen (TA)-specific T cell responses. However the underlying pathways remain ill defined. Here we identify that immunosuppressive cells (ISCs) from tumor-bearing mice impose metabolic stress on CD8+T cells, which is associated with increased expression of the co-inhibitor PD-1. In two mouse melanoma models, depleting FAP+ stroma cells from the tumor microenvironment (TME) upon vaccination with an adenoviral-vector reduces frequencies and functions of ISCs. This is associated with changes in the cytokine/chemokine milieu in the TME and decreased activity of STAT6 signaling within ISCs. Decreases in ISCs upon FAP+stromal cell depletion is associated with reduced metabolic stress of vaccine-induced tumor infiltrating CD8+T cells and their delayed progression towards functional exhaustion, resulting in prolonged survival of tumor-bearing mice.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 7818